Clinical trials
Recruiting Phase 2 Lymphoma, Non-Hodgkin trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 7 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 18 |
| 2025 | 6 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 50 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Memorial Sloan Kettering Cancer Center | 3 |
| Canadian Cancer Trials Group | 2 |
| M.D. Anderson Cancer Center | 2 |
| Miltenyi Biomedicine GmbH | 2 |
| National Cancer Institute (NCI) | 2 |
| New York Medical College | 2 |
| Thomas Jefferson University | 2 |
| Abramson Cancer Center at Penn Medicine | 1 |
| American Society of Clinical Oncology | 1 |
| Ascentage Pharma Group Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Non-Hodgkin | 50 |
| Hodgkin Disease | 15 |
| Myelodysplastic Syndromes | 11 |
| Leukemia, Myeloid, Acute | 10 |
| Lymphoma, Large B-Cell, Diffuse | 10 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 10 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 7 |
| Lymphoma, Follicular | 7 |
| Multiple Myeloma | 7 |
| Hematologic Neoplasms | 6 |
Trials
Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.